{"protocolSection": {"identificationModule": {"nctId": "NCT02892955", "orgStudyIdInfo": {"id": "MOMENTUM 3 CAP"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "MOMENTUM 3 Continued Access Protocol", "officialTitle": "Multi-Center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3\u2122 Continued Access Protocol: Post-Approval Continued Follow-up", "acronym": "MOMENTUM 3 CAP"}, "statusModule": {"statusVerifiedDate": "2022-06", "overallStatus": "COMPLETED", "startDateStruct": {"date": "2016-08", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2020-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2021-03", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-08-24", "studyFirstSubmitQcDate": "2016-09-01", "studyFirstPostDateStruct": {"date": "2016-09-08", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2022-01-04", "resultsFirstSubmitQcDate": "2022-02-09", "resultsFirstPostDateStruct": {"date": "2022-03-03", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-06-23", "lastUpdatePostDateStruct": {"date": "2022-06-27", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true}, "descriptionModule": {"briefSummary": "The objective of the study is to continue to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study.", "detailedDescription": "Enrollment in the CAP cohort ended shortly after approval for the long-term indication was received from the FDA in October 2018. As a condition of approval, all patients enrolled in the CAP cohort were to complete the 2-year follow-up to fulfil a post-approval study requirement."}, "conditionsModule": {"conditions": ["Advanced Refractory Left Ventricular Heart Failure"], "keywords": ["Heart Failure", "LVAS", "Ventricular Dysfunction", "Cardiomyopathy", "Heart Disease", "Cardiovascular Disease", "Heart-assist devices", "Thoratec Corporation"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 1685, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "HeartMate 3 LVAS (HM3 LVAS)", "type": "EXPERIMENTAL", "description": "The study was a single-arm, prospective, multi-center, study for continued evaluation of safety and clinical performance of the HM3 LVAS.", "interventionNames": ["Device: HeartMate 3 LVAS"]}], "interventions": [{"type": "DEVICE", "name": "HeartMate 3 LVAS", "description": "Implantation of HeartMate 3 LVAD to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the MOMENTUM 3 IDE Study.", "armGroupLabels": ["HeartMate 3 LVAS (HM3 LVAS)"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Event-Free Survival", "description": "Survival at 24 months free of disabling stroke (Modified Rankin Score \\> 3) or reoperation to replace or remove a malfunctioning device", "timeFrame": "Subjects will be followed for 24 months or to outcome (transplant, explant, or death), whichever occurs first."}], "secondaryOutcomes": [{"measure": "Pump Replacement", "description": "Frequency of HeartMate 3 pump replacement at 24 months.", "timeFrame": "As they occur up to 24 months or to outcome, whichever occurs first"}, {"measure": "Six Minute Walk Test (6MWT)", "description": "Functional status as measured by the Six Minute Walk Test. The Six Minute Walk Test measures the distance a patient is able to walk during 6 minutes without running or jogging.", "timeFrame": "Baseline, 6 months and 24 months"}, {"measure": "New York Heart Association (NYHA) Classification", "description": "Functional status as measured by NYHA classification. NYHA class categorizes patients by the severity of their heart failure symptoms. As the class increases, the degree of symptoms is more severe indicating worse functional status. Class I indicates no limitation of physical activity. Class II indicates slight limitation of physical activity. Class IIIA indicates marked limitation of physical activity where less than ordinary physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IIIB indicates marked limitation of physical activity where mild physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IV indicates inability to carry on any physical activity without discomfort.", "timeFrame": "Baseline, 6 months and 24 months"}, {"measure": "EuroQol-5D-5L Visual Analogue Scale", "description": "Quality of life as measured by the visual analogue scale from the EuroQol-5D-5L questionnaire. The patient rates their current state of health with the visual analogue scale. The scale ranges from 0 to 100. Higher scores indicate a better quality of life.", "timeFrame": "Baseline, 6 months and 24 months"}, {"measure": "Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score", "description": "Quality of Life as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ). Scores range from 0 to 100. Higher scores indicate better quality of life and fewer heart failure symptoms.", "timeFrame": "Baseline, 6 months and 24 months"}, {"measure": "Rehospitalizations", "description": "Rate of all cause rehospitalization", "timeFrame": "From initial discharge to 2 years post-implant"}, {"measure": "Adverse Event Rates", "description": "Events-per-patient-year (EPPY) for anticipated adverse events as defined in the study protocol", "timeFrame": "2 years post-implant"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Subject or legal representative has signed Informed Consent Form (ICF)\n2. Age \u2265 18 years\n3. BSA \u2265 1.2 m2\n4. NYHA Class III with dyspnea upon mild physical activity or NYHA Class IV\n5. LVEF \u2264 25%\n6. a) Inotrope dependent OR b) CI \\< 2.2 L/min/m2, while not on inotropes and subjects must also meet one of the following:\n\n   * On optimal medical management (OMM), based on current heart failure practice guidelines for at least 45 out of the last 60 days and are failing to respond\n   * Advanced heart failure for at least 14 days AND dependent on intra-aortic balloon pump (IABP) for at least 7 days,\n7. Females of child bearing age must agree to use adequate contraception\n\nExclusion Criteria:\n\n1. Etiology of HF due to or associated with uncorrected thyroid disease, obstructive cardiomyopathy, pericardial disease, amyloidosis, or restrictive cardiomyopathy\n2. Technical obstacles which pose an inordinately high surgical risk, in the judgment of the investigator\n3. Existence of ongoing mechanical circulatory support (MCS) other than IABP\n4. Positive pregnancy test if of childbearing potential\n5. Presence of mechanical aortic cardiac valve that will not be either converted to a bioprosthesis or oversewn at the time of LVAD implant\n6. History of any organ transplant\n7. Platelet count \\< 100,000 x 103/L (\\< 100,000/ml)\n8. Psychiatric disease/disorder, irreversible cognitive dysfunction or psychosocial issues that are likely to impair compliance with the study protocol and LVAS management\n9. History of confirmed, untreated Abdominal Aortic Aneurysm (AAA) \\> 5 cm in diameter within 6 months of enrollment\n10. Presence of an active, uncontrolled infection\n11. Intolerance to anticoagulant or antiplatelet therapies or any other peri/post-operative therapy that the investigator will require based upon the patients' health status\n12. Presence of any one of the following risk factors for indications of severe end organ dysfunction or failure:\n\n    * An INR \u2265 2.0 not due to anticoagulation therapy\n    * Total bilirubin \\> 43 umol/L (2.5 mg/dl), shock liver, or biopsy proven liver cirrhosis\n    * History of severe chronic obstructive pulmonary disease (COPD) defined by FEV1/FVC \\< 0.7, and FEV1 \\<50% predicted\n    * Fixed pulmonary hypertension with a most recent PVR \u2265 8 Wood units that is unresponsive to pharmacologic intervention\n    * History of stroke within 90 days prior to enrollment, or a history of cerebrovascular disease with significant (\\> 80%) uncorrected carotid artery stenosis\n    * Serum Creatinine \u2265 221 umol/L (2.5 mg/dl) or the need for chronic renal replacement therapy\n    * Significant peripheral vascular disease (PVD) accompanied by rest pain or extremity ulceration\n13. Patient has moderate to severe aortic insufficiency without plans for correction during pump implant\n14. Pre albumin \\< 150 mg/L (15mg/dL) or Albumin \\< 30g/L (3 g/dL) (if only one available); pre albumin \\< 150 mg/L (15mg/dL) and Albumin \\< 30g/L (3 g/dL) (if both available)\n15. Planned Bi-VAD support prior to enrollment\n16. Patient has known hypo or hyper coagulable states such as disseminated intravascular coagulation and heparin induced thrombocytopenia\n17. Participation in any other clinical investigation that is likely to confound study results or affect the study\n18. Any condition other than HF that could limit survival to less than 24 months\n19. Patients actively listed for heart transplant (this exclusion applies only after commercial approval of the HM3 for short-term use)", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "100 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Marie-Elena Brett", "affiliation": "Abbott Medical Devices", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Baptist Health Medical Center - Little Rock", "city": "Little Rock", "state": "Arkansas", "zip": "72205", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "Cedars Sinai Medical Center", "city": "Beverly Hills", "state": "California", "zip": "90211", "country": "United States", "geoPoint": {"lat": 34.07362, "lon": -118.40036}}, {"facility": "University of California, San Diego", "city": "La Jolla", "state": "California", "zip": "92037", "country": "United States", "geoPoint": {"lat": 32.84727, "lon": -117.2742}}, {"facility": "Sutter Memorial Hospital", "city": "Sacramento", "state": "California", "zip": "95816", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Sharp Memorial Hospital", "city": "San Diego", "state": "California", "zip": "92123", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"facility": "California Pacific Medical Center", "city": "San Francisco", "state": "California", "zip": "94115", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "Stanford University", "city": "Stanford", "state": "California", "zip": "94305", "country": "United States", "geoPoint": {"lat": 37.42411, "lon": -122.16608}}, {"facility": "University of Colorado Hospital", "city": "Aurora", "state": "Colorado", "zip": "80045", "country": "United States", "geoPoint": {"lat": 39.72943, "lon": -104.83192}}, {"facility": "Yale New Haven Hospital", "city": "New Haven", "state": "Connecticut", "zip": "06510", "country": "United States", "geoPoint": {"lat": 41.30815, "lon": -72.92816}}, {"facility": "MedStar Washington Hospital Center", "city": "Washington", "state": "District of Columbia", "zip": "20010", "country": "United States", "geoPoint": {"lat": 38.89511, "lon": -77.03637}}, {"facility": "Shands Hospital @ University of Florida", "city": "Gainesville", "state": "Florida", "zip": "32610", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"facility": "Florida Hospital", "city": "Orlando", "state": "Florida", "zip": "32804", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "Tampa General Hospital", "city": "Tampa", "state": "Florida", "zip": "33606", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Piedmont Heart Institute", "city": "Atlanta", "state": "Georgia", "zip": "30309", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Emory University Hospital", "city": "Atlanta", "state": "Georgia", "zip": "30322", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Northwestern Memorial Hospital", "city": "Chicago", "state": "Illinois", "zip": "60611", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "University of Chicago Medical Center", "city": "Chicago", "state": "Illinois", "zip": "60637", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Advocate Christ Medical Center", "city": "Oak Lawn", "state": "Illinois", "zip": "60453", "country": "United States", "geoPoint": {"lat": 41.71087, "lon": -87.75811}}, {"facility": "IU Health/Methodist Hospital", "city": "Indianapolis", "state": "Indiana", "zip": "46202", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "St. Vincent Hospital", "city": "Indianapolis", "state": "Indiana", "zip": "46260", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "University of Iowa Hospitals and Clinics", "city": "Iowa City", "state": "Iowa", "zip": "52242", "country": "United States", "geoPoint": {"lat": 41.66113, "lon": -91.53017}}, {"facility": "University of Kentucky - Saha Cardiovascular Research Center", "city": "Lexington", "state": "Kentucky", "zip": "40536", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "Jewish Hospital", "city": "Louisville", "state": "Kentucky", "zip": "40202", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"facility": "Ochsner Medical Center", "city": "New Orleans", "state": "Louisiana", "zip": "70121", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"facility": "Johns Hopkins Unversity Hospital", "city": "Baltimore", "state": "Maryland", "zip": "21287", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "Massachusetts General Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02214", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Brigham & Women's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02215", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "University of Michigan", "city": "Ann Arbor", "state": "Michigan", "zip": "48109", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}, {"facility": "Henry Ford Hospital", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Spectrum Health Butterworth Hospital", "city": "Grand Rapids", "state": "Michigan", "zip": "49503", "country": "United States", "geoPoint": {"lat": 42.96336, "lon": -85.66809}}, {"facility": "Abbott Northwestern Hospital", "city": "Minneapolis", "state": "Minnesota", "zip": "55407", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "University of Minnesota Medical Center, Fairview", "city": "Minneapolis", "state": "Minnesota", "zip": "55455", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "Mayo Clinic Rochester", "city": "Rochester", "state": "Minnesota", "zip": "55905", "country": "United States", "geoPoint": {"lat": 44.02163, "lon": -92.4699}}, {"facility": "Barnes Jewish Hospital", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "University of Nebraska Medical Center", "city": "Omaha", "state": "Nebraska", "zip": "63198", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "Newark Beth Israel Medical Center", "city": "Newark", "state": "New Jersey", "zip": "07112", "country": "United States", "geoPoint": {"lat": 40.73566, "lon": -74.17237}}, {"facility": "Montefiore Medical Center", "city": "Bronx", "state": "New York", "zip": "10467", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "Mt. Sinai Medical Center", "city": "New York", "state": "New York", "zip": "10029", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "Columbia University Medical Center", "city": "New York", "state": "New York", "zip": "10032", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "University of Rochester Medical Center", "city": "Rochester", "state": "New York", "zip": "14642", "country": "United States", "geoPoint": {"lat": 43.15478, "lon": -77.61556}}, {"facility": "University of North Carolina at Chapel Hill", "city": "Chapel Hill", "state": "North Carolina", "zip": "27599", "country": "United States", "geoPoint": {"lat": 35.9132, "lon": -79.05584}}, {"facility": "Carolinas Medical Center", "city": "Charlotte", "state": "North Carolina", "zip": "28206", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "Duke University Medical Center", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "University Hospitals of Cleveland", "city": "Cleveland", "state": "Ohio", "zip": "44106", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "Cleveland Clinic Foundation", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "Ohio State University Medical Center", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "INTEGRIS Baptist Medical Center", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73112", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Oregon Health and Science University", "city": "Portland", "state": "Oregon", "zip": "97239", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Hershey", "city": "Hershey", "state": "Pennsylvania", "zip": "17033", "country": "United States", "geoPoint": {"lat": 40.28592, "lon": -76.65025}}, {"facility": "Hospital of the University of Pennsylvania", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19104", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Thomas Jefferson University Hospital", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19107", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Allegheny General Hospital", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15212", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "University of Pittsburgh Medical Center", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15323", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Medical University of South Carolina", "city": "Charleston", "state": "South Carolina", "zip": "29425", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "St. Thomas West Hospital", "city": "Nashville", "state": "Tennessee", "zip": "37205", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Vanderbilt University Medical Center", "city": "Nashville", "state": "Tennessee", "zip": "37232", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Baylor Research Institute", "city": "Dallas", "state": "Texas", "zip": "75246", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Memorial Hermann Health Systems", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Methodist Houston", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Texas Heart Institute", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "University of Utah Hospital and Clinics", "city": "Salt Lake City", "state": "Utah", "zip": "84132", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "University of Virginia Medical Center", "city": "Charlottesville", "state": "Virginia", "zip": "22908", "country": "United States", "geoPoint": {"lat": 38.02931, "lon": -78.47668}}, {"facility": "Inova Fairfax Hospital", "city": "Falls Church", "state": "Virginia", "zip": "22042", "country": "United States", "geoPoint": {"lat": 38.88233, "lon": -77.17109}}, {"facility": "Sentara Norfolk General Hospital", "city": "Norfolk", "state": "Virginia", "zip": "23507", "country": "United States", "geoPoint": {"lat": 36.84681, "lon": -76.28522}}, {"facility": "Bon Secours St. Mary's Hospital", "city": "Richmond", "state": "Virginia", "zip": "23226", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "Virginia Commonwealth University", "city": "Richmond", "state": "Virginia", "zip": "23298", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "University of Washington Medical Center", "city": "Seattle", "state": "Washington", "zip": "98195", "country": "United States", "geoPoint": {"lat": 47.60621, "lon": -122.33207}}, {"facility": "University of Wisconsin Hospitals and Clinics", "city": "Madison", "state": "Wisconsin", "zip": "53792", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}, {"facility": "St. Luke's Medical Center", "city": "Milwaukee", "state": "Wisconsin", "zip": "53215", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}]}, "referencesModule": {"references": [{"pmid": "26670056", "type": "BACKGROUND", "citation": "Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Marasco S, Beyersdorf F, Damme L, Schmitto JD. Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. J Am Coll Cardiol. 2015 Dec 15;66(23):2579-2589. doi: 10.1016/j.jacc.2015.09.083."}, {"pmid": "26670057", "type": "BACKGROUND", "citation": "Uriel N, Adatya S, Mehra MR. Evolution in Mechanical Circulatory Support: Are We at the Precipice of a Disruptive Innovation? J Am Coll Cardiol. 2015 Dec 15;66(23):2590-2593. doi: 10.1016/j.jacc.2015.10.028. No abstract available."}, {"pmid": "25920932", "type": "BACKGROUND", "citation": "Schmitto JD, Hanke JS, Rojas SV, Avsar M, Haverich A. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). J Heart Lung Transplant. 2015 Jun;34(6):858-60. doi: 10.1016/j.healun.2015.03.001. Epub 2015 Mar 7. No abstract available."}, {"pmid": "27435529", "type": "BACKGROUND", "citation": "Netuka I, Kvasnicka T, Kvasnicka J, Hrachovinova I, Ivak P, Marecek F, Bilkova J, Malikova I, Jancova M, Maly J, Sood P, Sundareswaran KS, Connors JM, Mehra MR. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant. 2016 Jul;35(7):860-7. doi: 10.1016/j.healun.2016.05.019. Epub 2016 May 31."}, {"pmid": "27195742", "type": "BACKGROUND", "citation": "Bourque K, Cotter C, Dague C, Harjes D, Dur O, Duhamel J, Spink K, Walsh K, Burke E. Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility. ASAIO J. 2016 Jul-Aug;62(4):375-83. doi: 10.1097/MAT.0000000000000388."}, {"pmid": "27160494", "type": "BACKGROUND", "citation": "Hanke JS, Haverich A, Schmitto JD. Exchange of a HeartMate II left ventricular assist device with a HeartMate 3 pump. J Heart Lung Transplant. 2016 Jul;35(7):944-6. doi: 10.1016/j.healun.2016.03.013. Epub 2016 Mar 30. No abstract available."}, {"pmid": "27044532", "type": "BACKGROUND", "citation": "Heatley G, Sood P, Goldstein D, Uriel N, Cleveland J, Middlebrook D, Mehra MR; MOMENTUM 3 Investigators. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. J Heart Lung Transplant. 2016 Apr;35(4):528-36. doi: 10.1016/j.healun.2016.01.021. Epub 2016 Jan 30."}, {"pmid": "26944673", "type": "BACKGROUND", "citation": "Schulz A, Stepanenko A, Krabatsch T. HeartMate 3 implantation via left lateral thoracotomy with outflow graft anastomosis to the descending aorta. J Heart Lung Transplant. 2016 May;35(5):690-2. doi: 10.1016/j.healun.2016.01.004. Epub 2016 Jan 15. No abstract available."}, {"pmid": "27210469", "type": "BACKGROUND", "citation": "Stansfield WE, Rao V. HeartMate 3: Facing the challenge of past success. J Thorac Cardiovasc Surg. 2016 Sep;152(3):683-5. doi: 10.1016/j.jtcvs.2016.04.048. Epub 2016 Apr 22. No abstract available."}, {"pmid": "27349284", "type": "BACKGROUND", "citation": "Takayama H. Did you like Terminator 3 better than Terminator 2? \"Rise of machines\" with HeartMate 3? J Thorac Cardiovasc Surg. 2016 Sep;152(3):686-7. doi: 10.1016/j.jtcvs.2016.05.044. Epub 2016 Jun 2. No abstract available."}, {"pmid": "33932272", "type": "RESULT", "citation": "Mehra MR, Cleveland JC Jr, Uriel N, Cowger JA, Hall S, Horstmanshof D, Naka Y, Salerno CT, Chuang J, Williams C, Goldstein DJ; MOMENTUM 3 Investigators. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021 Aug;23(8):1392-1400. doi: 10.1002/ejhf.2211. Epub 2021 May 18."}, {"pmid": "35772857", "type": "DERIVED", "citation": "Vidula H, Takeda K, Estep JD, Silvestry SC, Milano C, Cleveland JC Jr, Goldstein DJ, Uriel N, Kormos RL, Dirckx N, Mehra MR. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. JACC Heart Fail. 2022 Jul;10(7):470-481. doi: 10.1016/j.jchf.2022.03.007. Epub 2022 Jun 8."}, {"pmid": "34525837", "type": "DERIVED", "citation": "Sheikh FH, Ravichandran AK, Goldstein DJ, Agarwal R, Ransom J, Bansal A, Kim G, Cleveland JC, Uriel N, Sheridan BC, Chomsky D, Patel SR, Dirckx N, Franke A, Mehra MR. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial. Circ Heart Fail. 2021 Oct;14(10):e008360. doi: 10.1161/CIRCHEARTFAILURE.120.008360. Epub 2021 Sep 16."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "The study will be a single-arm, prospective, multi-center, study for continued evaluation of safety and clinical performance of the HM3 LVAS.\n\nHeartMate 3 LVAS: Implantation of HeartMate 3 LVAD to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "1685"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "1685"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "The study will be a single-arm, prospective, multi-center, study for continued evaluation of safety and clinical performance of the HM3 LVAS.\n\nHeartMate 3 LVAS: Implantation of HeartMate 3 LVAD to evaluate safety and clinical performance of the HM3 LVAS for the treatment of advanced, refractory, left ventricular heart failure following completion of enrollment in the the MOMENTUM 3 IDE Study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "1685"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "59.9", "spread": "12.2"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "343"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "1342"}]}]}]}, {"title": "Race (NIH/OMB)", "description": "Participants in the \"more than one race\" category include those who also specified a race other than Asian, Native Hawaiian or Other Pacific Islander, Black or African American, or White race.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "19"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "10"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "466"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "1135"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "53"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "2"}]}]}]}, {"title": "INTERMACS Profile", "description": "Lower profiles are considered worse. Profile 1 describes patients in critical cardiogenic shock. Profile 2 describes patients with inotrope dependence who show signs of continuing deterioration. Profile 3 describes stable, inotrope dependent patients. Profile 4 describes patients at home on oral therapy with symptoms of congestion at rest. Profile 5 describes exertion intolerant patients who are comfortable at rest. Profile 6 describes exertion limited patients who are comfortable at rest. Profile 7 describes clinically stable patients with reasonable levels of comfortable activity.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "1", "measurements": [{"groupId": "BG000", "value": "69"}]}, {"title": "2", "measurements": [{"groupId": "BG000", "value": "517"}]}, {"title": "3", "measurements": [{"groupId": "BG000", "value": "843"}]}, {"title": "4", "measurements": [{"groupId": "BG000", "value": "216"}]}, {"title": "5", "measurements": [{"groupId": "BG000", "value": "24"}]}, {"title": "6 or 7", "measurements": [{"groupId": "BG000", "value": "1"}]}, {"title": "Not provided", "measurements": [{"groupId": "BG000", "value": "15"}]}]}]}, {"title": "Intended Goal of Support", "description": "Bridge to recovery: Use of a durable device to allow recovery from chronic cardiac failure. Rescue therapy: Use of a durable device to support resolution from an acute event without major previous cardiac dysfunction. Bridge to transplant: Patient listed for transplant or listed within 24 hours before device implantation. Bridge to candidacy: Patient may be eligible for transplant. Destination therapy: patient definitely not eligible for transplant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Bridge to Transplant", "measurements": [{"groupId": "BG000", "value": "173"}]}, {"title": "Bridge to Candidacy", "measurements": [{"groupId": "BG000", "value": "233"}]}, {"title": "Destination Therapy", "measurements": [{"groupId": "BG000", "value": "1274"}]}, {"title": "Bridge to Recovery", "measurements": [{"groupId": "BG000", "value": "4"}]}, {"title": "Rescue Therapy", "measurements": [{"groupId": "BG000", "value": "1"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Event-Free Survival", "description": "Survival at 24 months free of disabling stroke (Modified Rankin Score \\> 3) or reoperation to replace or remove a malfunctioning device", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Subjects will be followed for 24 months or to outcome (transplant, explant, or death), whichever occurs first.", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1685"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1320"}]}]}]}, {"type": "SECONDARY", "title": "Pump Replacement", "description": "Frequency of HeartMate 3 pump replacement at 24 months.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "As they occur up to 24 months or to outcome, whichever occurs first", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1685"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "20"}]}]}]}, {"type": "SECONDARY", "title": "Six Minute Walk Test (6MWT)", "description": "Functional status as measured by the Six Minute Walk Test. The Six Minute Walk Test measures the distance a patient is able to walk during 6 minutes without running or jogging.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment. Patients unable to walk due to heart failure symptoms were assigned a distance of zero.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Baseline, 6 months and 24 months", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1685"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1487"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "101.3", "spread": "160.7"}]}]}, {"title": "6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1140"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "317.2", "spread": "163.3"}]}]}, {"title": "24 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "664"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "305.1", "spread": "172.5"}]}]}]}, {"type": "SECONDARY", "title": "New York Heart Association (NYHA) Classification", "description": "Functional status as measured by NYHA classification. NYHA class categorizes patients by the severity of their heart failure symptoms. As the class increases, the degree of symptoms is more severe indicating worse functional status. Class I indicates no limitation of physical activity. Class II indicates slight limitation of physical activity. Class IIIA indicates marked limitation of physical activity where less than ordinary physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IIIB indicates marked limitation of physical activity where mild physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IV indicates inability to carry on any physical activity without discomfort.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline, 6 months and 24 months", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1685"}]}], "classes": [{"title": "NYHA Class I or II at Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1673"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Class I or II at 6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1344"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1046"}]}]}, {"title": "Class I or II at 24 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "949"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "686"}]}]}]}, {"type": "SECONDARY", "title": "EuroQol-5D-5L Visual Analogue Scale", "description": "Quality of life as measured by the visual analogue scale from the EuroQol-5D-5L questionnaire. The patient rates their current state of health with the visual analogue scale. The scale ranges from 0 to 100. Higher scores indicate a better quality of life.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "Baseline, 6 months and 24 months", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1685"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1602"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "48.3", "spread": "25.1"}]}]}, {"title": "6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1326"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "73.9", "spread": "18.2"}]}]}, {"title": "24 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "922"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "72.4", "spread": "20.1"}]}]}]}, {"type": "SECONDARY", "title": "Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score", "description": "Quality of Life as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ). Scores range from 0 to 100. Higher scores indicate better quality of life and fewer heart failure symptoms.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Score on a scale", "timeFrame": "Baseline, 6 months and 24 months", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1685"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1610"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40.0", "spread": "21.6"}]}]}, {"title": "6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1325"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "69.5", "spread": "20.0"}]}]}, {"title": "24 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "923"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "67.3", "spread": "21.8"}]}]}]}, {"type": "SECONDARY", "title": "Rehospitalizations", "description": "Rate of all cause rehospitalization", "populationDescription": "Subjects who were discharged on LVAD support from the implant hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "events per patient year", "timeFrame": "From initial discharge to 2 years post-implant", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1571"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.03"}]}]}]}, {"type": "SECONDARY", "title": "Adverse Event Rates", "description": "Events-per-patient-year (EPPY) for anticipated adverse events as defined in the study protocol", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "events per patient year", "timeFrame": "2 years post-implant", "groups": [{"id": "OG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1685"}]}], "classes": [{"title": "Arterial Non-CNS Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01"}]}]}, {"title": "Bleeding", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.71"}]}]}, {"title": "Cardiac Arrhythmia", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.30"}]}]}, {"title": "Hepatic Dysfunction", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04"}]}]}, {"title": "Hypertension", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04"}]}]}, {"title": "Major Infection", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.73"}]}]}, {"title": "Myocardial Infarction", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01"}]}]}, {"title": "Stroke", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07"}]}]}, {"title": "Other Neurological Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.09"}]}]}, {"title": "Pericardial Fluid Collection", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04"}]}]}, {"title": "Psychiatric Episode", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07"}]}]}, {"title": "Renal Dysfunction", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.11"}]}]}, {"title": "Respiratory Failure", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.16"}]}]}, {"title": "Right Heart Failure", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.27"}]}]}, {"title": "Venous Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03"}]}]}, {"title": "Wound Dehiscence", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00"}]}]}, {"title": "Suspected Device Thrombosis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01"}]}]}, {"title": "Hemolysis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.00"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "2 years post-implant", "description": "Serious adverse events are defined as those adverse events causing death, or congenital abnormality or birth defect, or a life-threatening illness or injury that results in permanent disability, requires hospitalization, or prolongs a hospitalization, and/or requires intervention to prevent permanent injury or damage.", "eventGroups": [{"id": "EG000", "title": "HeartMate 3 LVAS (HM3 LVAS)", "description": "Patients implanted with HeartMate 3 LVAS and enrolled in the MOMENTUM 3 CAP cohort.", "deathsNumAffected": 293, "deathsNumAtRisk": 1685, "seriousNumAffected": 1536, "seriousNumAtRisk": 1685, "otherNumAffected": 1050, "otherNumAtRisk": 1685}], "seriousEvents": [{"term": "Protocol defined bleeding", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 802, "numAtRisk": 1685}]}, {"term": "Protocol defined hemolysis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 1685}]}, {"term": "Protocol defined cardiac arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 473, "numAtRisk": 1685}]}, {"term": "Protocol defined myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 15, "numAtRisk": 1685}]}, {"term": "Protocol defined pericardial fluid collection", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 96, "numAtRisk": 1685}]}, {"term": "Protocol defined right heart failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 541, "numAtRisk": 1685}]}, {"term": "Protocol defined other adverse event", "organSystem": "General disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 1084, "numAtRisk": 1685}]}, {"term": "Protocol defined hepatic dysfunction", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 58, "numAtRisk": 1685}]}, {"term": "Protocol defined major infection", "organSystem": "Infections and infestations", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 862, "numAtRisk": 1685}]}, {"term": "Protocol defined stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 153, "numAtRisk": 1685}]}, {"term": "Protocol defined other neurological event", "organSystem": "Nervous system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 202, "numAtRisk": 1685}]}, {"term": "Protocol defined suspected device thrombosis", "organSystem": "Product Issues", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 18, "numAtRisk": 1685}]}, {"term": "Protocol defined psychiatric episode", "organSystem": "Psychiatric disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 73, "numAtRisk": 1685}]}, {"term": "Protocol defined renal dysfunction", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 231, "numAtRisk": 1685}]}, {"term": "Protocol defined respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 325, "numAtRisk": 1685}]}, {"term": "Protocol defined wound dehiscence", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 1685}]}, {"term": "Protocol defined arterial non-CNS thromboembolism", "organSystem": "Vascular disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 21, "numAtRisk": 1685}]}, {"term": "Protocol defined hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 45, "numAtRisk": 1685}]}, {"term": "Protocol defined venous thromboembolism", "organSystem": "Vascular disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 30, "numAtRisk": 1685}]}], "otherEvents": [{"term": "Protocol defined bleeding", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 107, "numAtRisk": 1685}]}, {"term": "Protocol defined cardiac arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 135, "numAtRisk": 1685}]}, {"term": "Protocol defined major infection", "organSystem": "Infections and infestations", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 267, "numAtRisk": 1685}]}, {"term": "Protocol defined psychiatric episode", "organSystem": "Psychiatric disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 94, "numAtRisk": 1685}]}, {"term": "Protocol defined right heart failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 107, "numAtRisk": 1685}]}, {"term": "Protocol defined other adverse event", "organSystem": "General disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Events categorized based on detailed definition specified in the study protocol.", "stats": [{"groupId": "EG000", "numAffected": 617, "numAtRisk": 1685}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "This is a single arm study."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "MOMENTUM 3 studies have a study specific charter that governs the overall publication and presentation policy for all abstracts and manuscripts related to MOMENTUM 3 clinical data."}, "pointOfContact": {"title": "Joyce Chuang", "organization": "Abbott", "email": "joyce.chuang@abbott.com", "phone": "9253535817"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2019-01-14", "uploadDate": "2021-12-21T11:17", "filename": "Prot_SAP_000.pdf", "size": 975196}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M12154", "name": "Cardiomyopathies", "relevance": "LOW"}, {"id": "M20824", "name": "Ventricular Dysfunction", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}